teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests Projects Releases Packages Wiki Activity Actions 157
teleo-codex/entities/health/icer.md
Teleo Agents fe2380ce17 vida: extract claims from 2026-04-23-icer-glp1-affordable-access-2025 
- Source: inbox/queue/2026-04-23-icer-glp1-affordable-access-2025.md
- Domain: health
- Claims: 1, Entities: 1
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
2026-04-23 04:25:36 +00:00

1.2 KiB
Raw Blame History

Institute for Clinical and Economic Review (ICER)

Overview

ICER is the most rigorous independent health technology assessment organization in the United States, conducting evidence-based evaluations of medical interventions and their cost-effectiveness.

Timeline

  • 2025-04-09 — Published white paper "Affordable Access to GLP-1 Obesity Medications: Strategies to Guide Market Action and Policy Solutions" in collaboration with Brown University, synthesizing literature and stakeholder interviews (PBMs, manufacturers, patient advocacy groups, benefit consultants, state/Medicaid experts)

Significance

ICER's April 2025 GLP-1 white paper was criticized by the National Pharmaceutical Council for "prioritizing payers over patients," reflecting the structural tension between cost-effectiveness analysis and access equity. The white paper focuses on payer sustainability strategies rather than access expansion, documenting that self-insured employers saw >10x PMPM cost increases from January 2023 to December 2024.

Related Work

A peer-reviewed version of the white paper was published as "Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the US" (PMC12403326).